Pharmaceutical companies in the region are starting to take more interest in biologics and biosimilars, and of course with that, we see more interest in devices... Read more
Singapore: Researchers from the Department of Biochemistry of University of Hong Kong's (HKU) Li Ka Shing Faculty of Medicine have identified Lamin A protein as... Read more
Singapore: PATH's drug development program announced the successful completion of a phase IIIb clinical trial in Bangladesh for the antibiotic Paromomycin intramuscular... Read more
Singapore: Israel-based Teva Pharmaceutical and Canada-based Xenon Pharmaceuticals have entered into a collaborative development and exclusive worldwide license... Read more
Telemedicine is re-defining access to healthcare in many ways. It has, in particular, proved to be an effective solution in providing specialty healthcare, improving... Read more
Bioscience companies across Asia are witnessing a silent shift in the way they operate and promote innovation. These companies, now, are actively working at a cross... Read more
The medical devices industry has progressed by leaps and bounds in the recent past and this is evident from the several innovative strides that some of the firms... Read more
Contract and clinical research organizations (CROs) in the Asia Pacific (APAC) region are increasingly being leveraged by the biopharma industry to counter challenges... Read more
Singapore: Korea Health Industry Development Institute (KHIDI) has signed a memorandum of agreement (MoA) for healthcare cooperation with the UAE Armed Forces on... Read more
Survey Box
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
Australia
China
India
Japan
Korea
Malaysia
New Zealand 
Singapore
Taiwan
Thailand
